By suppressing pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukins, and inhibiting nuclear factor-kappa B (NF-κB) signaling, tilianin helps mitigate chronic inflammation—a hallmark of autoimmune, cardiovascular, and metabolic diseases [9, 10]. The gene discussed is TNF; the disease is metabolic disease.